David C Rees Selected Research

David C Rees Research Topics

Disease

32	Sickle Cell Anemia (Hemoglobin S Disease) 10/2022 - 07/2005
8	Pain (Aches) 01/2022 - 01/2015
7	Hemolysis 01/2022 - 10/2007
7	Neoplasms (Cancer) 10/2021 - 10/2007
5	Thalassemia 10/2022 - 02/2016
5	Inflammation (Inflammations) 01/2022 - 10/2007
5	Acute Intermittent Porphyria (Porphyria, Acute) 11/2020 - 01/2014
3	Acute Pain 01/2022 - 10/2007
3	Cerebral Infarction 01/2022 - 06/2006
3	Porphyrias (Porphyria) 11/2020 - 01/2014
3	Dehydration (Water Stress) 01/2019 - 09/2014
3	Infarction (Infarctions) 01/2018 - 06/2006
2	Hypoxia (Hypoxemia) 01/2021 - 09/2014
2	Sickle Cell Trait 01/2021 - 12/2006
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 07/2017
2	Hemolytic Anemia 01/2019 - 08/2010
2	Stroke (Strokes) 01/2018 - 01/2017
2	Thrombophilia 01/2018 - 02/2012
2	Hemorrhage 02/2016 - 02/2016
2	Hepatic Porphyrias (Hepatic Porphyria) 02/2013 - 08/2012
1	Proteinuria 10/2022
1	Infections 01/2022
1	Fatigue 01/2022
1	Airway Obstruction (Choking) 10/2021
1	Acidosis 01/2021
1	Malaria 01/2021
1	Body Weight (Weight, Body) 11/2020
1	Injection Site Reaction 11/2020
1	Ischemic Stroke 10/2020
1	Acute Chest Syndrome 11/2019
1	Pyruvate Kinase Deficiency of Red Cells 01/2019
1	Heart Failure 01/2018
1	Atherosclerosis 01/2018

Drug/Important Bio-Agent (IBA)

6	Oxygen (Dioxygen)IBA 01/2022 - 07/2009
5	Biomarkers (Surrogate Marker)IBA 12/2019 - 10/2007
5	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2019 - 07/2005
4	CationsIBA 10/2022 - 09/2014
4	Hemoglobins (Hemoglobin)IBA 10/2022 - 06/2008
4	PorphobilinogenIBA 11/2020 - 08/2012
4	AcidsIBA 01/2019 - 08/2012
4	EnzymesIBA 01/2019 - 01/2014
4	Cell-Free Nucleic AcidsIBA 09/2008 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
3	Sickle HemoglobinIBA 01/2021 - 02/2016
3	Heme (Haem)IBA 01/2020 - 01/2014
3	Prasugrel Hydrochloride FDA Link 07/2017 - 02/2016
3	Air Pollutants (Pollutants, Air)IBA 01/2017 - 06/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2007 - 12/2006
2	Polysaccharides (Glycans)IBA 01/2022 - 01/2021
2	Mannose (D-Mannose)IBA 01/2022 - 01/2021
2	ASTX029IBA 10/2021 - 01/2021
2	Acute Hepatic PorphyriaIBA 11/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 10/2020 - 07/2017
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018 - 08/2015
2	Fetal Hemoglobin (Hemoglobin F)IBA 01/2018 - 12/2017
1	Erythropoietin FDA Link 10/2022
1	SymportersIBA 10/2022
1	Potassium Chloride FDA LinkGeneric 10/2022
1	PotassiumIBA 10/2022
1	SodiumIBA 10/2022
1	Mannose ReceptorIBA 01/2022
1	CytokinesIBA 01/2022
1	canakinumab FDA Link 01/2022
1	Mannose-Binding LectinsIBA 01/2022
1	InflammasomesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2021
1	montelukast (Singulair)FDA Link 10/2021
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 10/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	LigandsIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	CreatinineIBA 11/2020
1	Transaminases (Aminotransferases)IBA 11/2020
1	givosiranIBA 11/2020
1	Hemin (Panhematin)FDA Link 11/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	Ceruloplasmin (Ferroxidase)IBA 01/2019
1	Factor XII (Hageman Factor)IBA 01/2019
1	GlobinsIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	HaptoglobinsIBA 01/2019
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2019
1	CD5 AntigensIBA 01/2019
1	GBT1118IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Vitamin D-Binding ProteinIBA 01/2019
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2018
1	Xanthine OxidaseIBA 01/2018
1	Complement C1s (C1 Esterase)IBA 01/2018

Therapy/Procedure

5	Therapeutics 12/2019 - 06/2006
4	Blood Transfusion (Blood Transfusions) 01/2017 - 06/2006
2	Critical Care (Surgical Intensive Care) 09/2010 - 09/2010
1	RNAi Therapeutics 11/2020
1	Intravenous Administration 11/2020
1	Contraindications 01/2018